These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15243118)

  • 1. Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient.
    Brandt ME; Kauffman CA; Pappas PG; Iqbal N; Arthington-Skaggs BA; Lee-Yang W; Smith MT
    J Clin Microbiol; 2004 Jul; 42(7):3363-5. PubMed ID: 15243118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Candida fabianii as a cause of lethal septicaemia.
    Valenza G; Valenza R; Brederlau J; Frosch M; Kurzai O
    Mycoses; 2006 Jul; 49(4):331-4. PubMed ID: 16784449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
    Imhof A; Balajee SA; Fredricks DN; Englund JA; Marr KA
    Clin Infect Dis; 2004 Sep; 39(5):743-6. PubMed ID: 15356792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
    Khan ZU; Al-Sweih NA; Ahmad S; Al-Kazemi N; Khan S; Joseph L; Chandy R
    J Clin Microbiol; 2007 Jun; 45(6):2025-7. PubMed ID: 17428940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
    Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
    Myoken Y; Kyo T; Sugata T; Murayama SY; Mikami Y
    Haematologica; 2006 Feb; 91(2):287-8. PubMed ID: 16461328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
    Kennedy HF; Shankland GS; Bagg J; Chalmers EA; Gibson BE; Williams CL
    Mycoses; 2006 Nov; 49(6):457-62. PubMed ID: 17022761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Yeast susceptibility isolated from blood cultures of patients at the National Cardiology Institute Ignacio Chávez].
    Hernández-Dueñas AM; Vázquez-Larios Mdel R; Soto-Nieto GI; Rivera-Martínez E
    Rev Invest Clin; 2009; 61(4):294-9. PubMed ID: 19848306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
    da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous mycosis and fungemia by Aureobasidium pullulans: a rare pathogenic fungus in a post allogeneic BM transplant patient.
    Joshi A; Singh R; Shah MS; Umesh S; Khattry N
    Bone Marrow Transplant; 2010 Jan; 45(1):203-4. PubMed ID: 19483761
    [No Abstract]   [Full Text] [Related]  

  • 13. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
    Jantunen E; Nihtinen A; Volin L; Juvonen E; Parkkali T; Ruutu T; Anttila VJ
    Bone Marrow Transplant; 2004 Nov; 34(10):891-5. PubMed ID: 15517009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.
    Cuenca-Estrella M; Rodriguez D; Almirante B; Morgan J; Planes AM; Almela M; Mensa J; Sanchez F; Ayats J; Gimenez M; Salvado M; Warnock DW; Pahissa A; Rodriguez-Tudela JL;
    J Antimicrob Chemother; 2005 Feb; 55(2):194-9. PubMed ID: 15618284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidaemia and antifungal susceptibility testing in a teaching hospital.
    Tzar MN; Shamim AS
    Med J Malaysia; 2009 Mar; 64(1):61-4. PubMed ID: 19852325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM; Prigitano A; Biraghi E; Viviani MA;
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC; Lo HJ; Fung CP; Lee N; See LC
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
    Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.